Scrub Typhus – A Comprehensive Medical Guide

Overview

Scrub typhus (also called tsutsugamushi disease) is an acute, febrile illness caused by the bacterium Orientia tsutsugamushi. The organism is transmitted to humans through the bite of infected larval trombiculid mites (commonly known as chiggers). The disease is endemic in a region called the “tsutsugamushi triangle,” which stretches from northern Japan and far-eastern Russia, across the Korean Peninsula, Taiwan, and China, through Southeast Asia, to northern Australia and the islands of the western Pacific.

Each year, an estimated 1–3 million cases of scrub typhus occur worldwide, resulting in up to 60,000 deaths if untreated (WHO, 2022). While the disease can affect anyone who enters mite‑infested environments, it most commonly occurs in:

• Agricultural workers and rice‑field laborers
• Military personnel deployed in endemic regions
• Travelers and trekkers in rural, forested, or scrubby terrain

The incidence shows a seasonal pattern, usually peaking during the rainy or warm months when chigger populations are highest.

Symptoms

Symptoms typically appear 6–21 days after the bite (incubation period). The clinical picture can be highly variable, ranging from a mild, flu‑like illness to severe, life‑threatening organ dysfunction. Below is a complete list of common and less frequent manifestations.

Early (Prodromal) Symptoms (Days 1–5)

• Fever – sudden onset, often >38.5 °C (101.3 °F)
• Headache – throbbing, sometimes described as “band‑like”
• Myalgia – muscle aches, especially in the lower back and thighs
• Dry cough or mild sore throat
• Loss of appetite and nausea

Characteristic Skin Findings (Days 4–7)

• Eschar – a painless, dark, necrotic crust surrounded by a reddened halo; the “black spot” is pathognomonic and can appear at the bite site (often hidden on the trunk, genitalia, or scalp).
• Rash – maculopapular or erythematous lesions that begin on the trunk and spread to the limbs; may become petechial or vesicular.

Systemic Involvement (Days 5–14)

• Respiratory: cough, dyspnea, occasional pneumonitis
• Cardiovascular: tachycardia, myocarditis, pericardial effusion (rare)
• Gastrointestinal: abdominal pain, diarrhea, vomiting
• Renal: oliguria, rising creatinine (acute kidney injury)
• Neurologic: confusion, delirium, encephalitis, meningismus, seizures (in severe cases)
• Hepatic: enlarged liver, mild jaundice, elevated transaminases

Recovery Phase

With appropriate therapy, fever usually subsides within 48–72 hours and most patients improve over 1–2 weeks. Relapse is uncommon but can occur if treatment is stopped prematurely.

Causes and Risk Factors

Microbiologic Cause

Orientia tsutsugamushi is an obligate intracellular gram‑negative bacterium that replicates within endothelial cells. The bacterium is maintained in nature through a sylvatic cycle involving small mammals (e.g., rodents) and mite larvae. Humans are accidental hosts.

How Transmission Occurs

• When an infected chigger larva attaches to the skin, it feeds for several days, injecting the bacteria with its saliva.
• Unlike adult ticks, chiggers do not remain attached for long; the eschar forms after the larva drops off.

Key Risk Factors

• Geographic exposure to endemic zones (see Overview).
• Occupational exposure – farming, forestry, military training, and outdoor construction.
• Seasonality – rainy or humid months increase chigger density.
• Clothing – wearing short sleeves, shorts, or sandals provides easier access for larvae.
• Personal habits – sleeping on the ground, sitting on low vegetation, or camping without proper gear.

Diagnosis

Prompt diagnosis is crucial because early treatment dramatically reduces morbidity and mortality. Clinicians rely on a combination of epidemiologic clues, physical findings (especially the eschar), and laboratory testing.

Clinical Diagnosis

• History of travel or residence in an endemic area.
• Fever with an eschar or typical rash.
• Exclusion of other febrile illnesses (e.g., dengue, malaria, leptospirosis).

Laboratory Tests

1. Serology – Indirect immunofluorescence assay (IFA) is the gold standard; a four‑fold rise in IgM or IgG titers between acute and convalescent samples confirms infection. Rapid IgM ELISA kits are increasingly available in endemic regions.
2. Polymerase Chain Reaction (PCR) – Detects O. tsutsugamushi DNA in blood, eschar tissue, or buffy coat; useful early before antibodies develop.
3. Culture – Requires biosafety level‑3 labs; not practical for routine diagnosis.
4. Complete blood count (CBC) – Often shows leukocytosis or leukopenia, thrombocytopenia.
5. Liver function tests – Mild to moderate elevation of AST/ALT.
6. Renal panel – May reveal rising creatinine in severe disease.

Imaging (when indicated)

• Chest X‑ray – to assess for pneumonitis or pleural effusion.
• Ultrasound/CT abdomen – if organomegaly or ascites suspected.

Treatment Options

Effective antimicrobial therapy can shorten illness duration and prevent complications. Choice of drug depends on disease severity, patient age, pregnancy status, and local antibiotic resistance patterns.

First‑Line Antibiotics

• Doxycycline 100 mg orally twice daily for 7‑10 days (or 200 mg loading dose then 100 mg daily). Most guidelines recommend doxycycline as the drug of choice for adults.
• Azithromycin 500 mg orally once daily for 5 days – preferred for pregnant women, children <8 years, and patients with doxycycline contraindications.

Alternative/Second‑Line Agents

• Chloramphenicol 500 mg IV/PO every 6 hours (used where doxycycline resistance is suspected).
• Levofloxacin 500 mg daily for 7 days – may be considered in areas with high doxycycline failure.

Supportive Care

• Intravenous fluids for dehydration.
• Antipyretics (acetaminophen) for fever and headache.
• Oxygen or ventilatory support for severe respiratory compromise.
• Renal replacement therapy if acute kidney injury progresses.

Duration of Therapy

Standard courses last 7–10 days. In immunocompromised patients or those with severe disease, extending therapy to 14 days may be necessary, guided by clinical response and repeat serology.

Living with Scrub Typhus

Most patients recover fully with timely treatment, but a few may experience lingering fatigue or mild hepatic dysfunction. Below are practical tips for a smooth convalescence.

• Rest and hydration – Aim for 2‑3 liters of fluids daily unless contraindicated.
• Nutrition – A balanced diet rich in protein and vitamins supports tissue repair.
• Medication adherence – Complete the full antibiotic course even if you feel better.
• Monitoring – Keep a log of temperature, urine output, and any new symptoms; report worsening signs to your clinician.
• Follow‑up labs – Repeat CBC, liver, and renal panels 1–2 weeks after therapy to confirm resolution.
• Psychological health – Some patients experience anxiety after a severe febrile illness; consider counseling if needed.

Prevention

Because there is currently no licensed vaccine for scrub typhus in most countries, prevention centers on reducing exposure to infected chiggers.

Personal Protective Measures

• Wear long sleeves, long trousers, and closed shoes when entering scrubby or forested areas.
• Apply repellents containing 20‑30% DEET to skin and clothing; reapply every 4‑6 hours.
• Use permethrin‑treated clothing or gear (permethrin is not applied directly to skin).
• Stay on cleared paths; avoid sitting or sleeping directly on grass or low vegetation.
• Shower and launder clothing in hot water (≥60 °C) within 2 hours of returning from the field to kill any attached mites.

Environmental Controls

• Clear vegetation around homes and campsites.
• Use rodent control measures, as rodents are reservoir hosts.
• Apply acaricides (mite‑killing sprays) in high‑risk occupational settings, following local safety guidelines.

Travel Advice

• Consult a travel medicine specialist before visiting endemic regions.
• Carry a small supply of doxycycline (if not contraindicated) for post‑exposure prophylaxis—some experts recommend a single 200 mg dose within 48 hours after a known bite, though evidence is limited.

Complications

If untreated or inadequately treated, scrub typhus can progress to severe, multi‑organ disease. Reported complications include:

• Acute respiratory distress syndrome (ARDS) – occurs in up to 20% of severe cases.
• Acute kidney injury – may require dialysis.
• Hepatitis – severe transaminase elevation and, rarely, fulminant liver failure.
• Myocarditis and pericarditis – can lead to arrhythmias.
• Encephalitis or meningitis – presenting with seizures, coma, or focal neurological deficits.
• Disseminated intravascular coagulation (DIC) – manifesting as bleeding and thrombosis.
• Mortality – reported case‑fatality rates range from <1% (treated) to 30% (untreated) in some outbreaks (CDC, 2023).

When to Seek Emergency Care

References

1. Mayo Clinic. “Scrub Typhus.” https://www.mayoclinic.org. Accessed May 2026.
2. World Health Organization. “Scrub Typhus Fact Sheet.” 2022. https://www.who.int.
3. Centers for Disease Control and Prevention. “Scrub Typhus.” 2023. https://www.cdc.gov.
4. National Institutes of Health, National Institute of Allergy and Infectious Diseases. “Orientia tsutsugamushi (Scrub Typhus).” 2021.
5. Cleveland Clinic. “Scrub Typhus.” 2022. https://my.clevelandclinic.org.
6. Kim DM, et al. “Clinical Manifestations and Outcomes of Scrub Typhus in the 21st Century.” *Lancet Infectious Diseases*, 2020;20(9):e275‑e283.